Introduction
============

The first 13 nuclear divisions in the *Drosophila* embryo have a streamlined cell cycle in which nuclei synchronously oscillate between S phase and mitosis independent of zygotic transcription ([@bib12]). Maternal RNAs and proteins deposited during oogenesis guide cell cycle progression. Cycles 1--9 occur deep in a common cytoplasm and are of equal duration. At the close of cycle 9, nuclei reach the embryo surface forming a blastoderm, and undergo 4 additional mitotic cycles where interphase (and S phase) gets progressively longer. At cycle 14 bulk zygotic transcription begins, many maternal products are degraded, nuclei are cellularized, and S phase significantly lengthens ([@bib8]; [@bib9]). These events in cycle 14 are collectively known as the mid-blastula transition (MBT).

The MBT is accompanied by changes in cell cycle regulation ([@bib26]). In cycle 14, maternal Cdc25 phosphatase is degraded and cells arrest in the first G2 due to inhibitory phosphorylation of cyclin-dependent kinase 1 (Cdk1) ([@bib6]; [@bib11]). Patterned zygotic transcription of Cdc25^string^ during G2 in cycle 14 relieves Cdk1 inhibition and directs mitosis in a matching pattern ([@bib7]). In contrast, Cdc25 is abundant during the maternally driven cycles and there is little inhibitory phosphorylation of Cdk1 ([@bib11]; [@bib37]). It has been suggested that accumulation of cyclin to some critical threshold times Cdk1 activation ([@bib25]; [@bib11]; [@bib36]; [@bib18]; [@bib4]). However, the bulk levels of mitotic cyclin exhibit little oscillation during the *Drosophila* maternally driven cycles ([@bib11]), and recent experiments ruled out mitotic cyclin accumulation as the direct timer of mitotic entry ([@bib22]; [@bib23]).

The fast maternally driven cycles have altered checkpoint responsiveness. Arresting DNA replication during the maternal cycles extends interphase, but does not block nuclei from entering mitoses ([@bib29]; [@bib34]). Flies mutant for genes in the DNA damage checkpoint, *mei41*, *grapes (grp)*, or *mus304*, are viable, but eggs laid from homozygous mutant mothers fail to normally prolong interphase during cycles 10--13 and ultimately enter a catastrophic mitosis in cycle 13 ([@bib13]; [@bib34], [@bib35]). Models attribute the normal interphase extension to prolongation of S phase and consequent activation of the checkpoint genes. Although the results indeed showed that Grapes is required to delay mitosis, the idea that the duration of DNA replication is the master timer of the early cycles is inferred from the common involvement of S phase in checkpoint activation. Thus, the contribution of a normal S phase in timing the early embryonic cycles has not been directly demonstrated.

In contrast to inhibition of DNA replication, which generally activates the S phase checkpoint, some modes of preventing S phase do not arrest the cell cycle. Cells mutant in genes required for the initial licensing of origins, such as the yeast gene *CDC6* and the *Drosophila* gene *double-parked* (*dup*, a homologue of yeast *CDT1*) fail to replicate their DNA, yet they enter mitosis with unreplicated sister chromatids ([@bib19]; [@bib27]; [@bib40]). Addition of the Dup inhibitor, Geminin, to *Xenopus* egg extracts or its overexpression in flies prevents the loading of the MCM helicase complex, and blocks the licensing step of DNA replication ([@bib24]; [@bib28]). We reasoned that injection of recombinant Geminin into syncytial *Drosophila* embryos would similarly block DNA replication licensing, delete S phase ([Fig. 1 B](#fig1){ref-type="fig"}), and thereby allow us to directly assess an S phase contribution in timing the cell cycle.

![**Injection of Geminin during the *Drosophila* blastoderm divisions deletes S phase and advances mitosis.** (A) Schematic illustrating progression through the blastoderm divisions and the MBT. The bar beneath the graph represents time. Cdc25^stg^ protein declines during the blastoderm cycles. Zygotic transcription of Cdc25^stg^ during G2 of cycle 14 promotes mitosis. (B) Schematic illustrating DNA replication initiation and experimental expectation from Geminin injection. (C) Nuclei of YFP-PCNA--expressing embryos in the cycle after injection of Geminin or control buffer. YFP-PCNA exhibits distinct nuclear foci in control injections. Arrows highlight foci in the apical region of nuclei at the end of S phase. Note that YFP-PCNA foci are absent throughout S phase after Geminin injection. Frames 9:56 and 11:48 of the Geminin-injected embryo correspond to premature mitotic entry and dispersal of nuclear YFP-PCNA in the cytoplasm. (D) YFP-PCNA--expressing embryos were injected in cycle 11 or cycle 12 with Geminin and interphase length and mitosis were measured in the subsequent cycle (cycle 12 or cycle 13, respectively). Interphase was defined by nuclear localization of PCNA and mitosis was defined by its dispersal. Average cell cycle times are shown for cycle 12 (*n* = 7 embryos) and cycle 13 (*n* = 10 embryos). Error bars represent SD.](JCB_200906191_GS_Fig1){#fig1}

Injection of Geminin prevented S phase in the ensuing cycle and advanced mitotic entry during the syncytial blastoderm divisions to give interphase durations similar to those in *grp* mutant embryos. After S phase deletion, nuclei entered mitosis with uninemic chromosomes, failed to achieve a metaphase alignment, and subsequently exited mitosis after a delay. We conclude that normal S phase delays mitotic entry during the maternal blastoderm divisions. Preventing S phase at the MBT in cycle 14 caused an extra syncytial division, uncovering a role for S phase 14 in the termination of the maternal mitotic program. Interestingly, deleting S phase in cycle 15 did not significantly alter the timing of mitosis. We suggest that the shift in regulation of Cdk1 activation to dependency on transcription of Cdc25 at the MBT supersedes the inputs from DNA replication.

Results and discussion
======================

Geminin injection deletes S phase and advances blastoderm mitoses
-----------------------------------------------------------------

If Geminin injection blocks the licensing of origins, it should affect the S phase occurring subsequent to licensing. Recruitment of MCM proteins to anaphase chromosomes during the early embryonic cycles marks the time of licensing ([@bib38]). Geminin injection during interphase 13 did not affect the progression of nuclei through mitosis 13, but did block the incorporation of dUTP in cycle 14, demonstrating the expected second cycle effect ([Fig. S1](http://www.jcb.org/cgi/content/full/jcb.200906191/DC1)).

Embryos expressing YFP-PCNA were used to follow S phase in real time. PCNA, a sliding clamp for DNA polymerase, localizes to the nucleus during interphase and forms foci at active sites of DNA replication ([@bib17]). Although the syncytial S phases of *Drosophila* are incredibly rapid, distinct foci of YFP-PCNA were evident throughout S phase and were especially prominent during the closing minutes of cycle 13 in the apical region of nuclei ([Fig. 1 C](#fig1){ref-type="fig"} and [Video 1](http://www.jcb.org/cgi/content/full/jcb.200906191/DC1)).

Consistent with a second cycle block to S phase, Geminin injection did not immediately disturb YFP-PCNA foci and a successful mitosis followed ([Video 2](http://www.jcb.org/cgi/content/full/jcb.200906191/DC1) and unpublished data). However, YFP-PCNA foci were not evident in the subsequent interphase ([Fig. 1 C](#fig1){ref-type="fig"} and Video 2). Likewise, when Geminin was injected at the beginning of cycle 14, defects appeared only 2.5 h later when cells began to collect in a prolonged mitosis 15 with unreplicated chromatids. The successful execution of cellularization, gastrulation, mitosis 14, and germband extension in these embryos implies that gene expression and general cell biological functions are not disturbed by Geminin injection, attesting to the specificity of its action.

We used real-time records of YFP-PCNA to determine how S phase deletion affects interphase duration. After Geminin injection, interphase was shortened by 37% in cycle 12 and by 51% in cycle 13 ([Fig. 1 D](#fig1){ref-type="fig"}). We note that a brief interphase remains in the absence of S phase, suggesting that inhibitors such as phosphatases or low mitotic activators can limit progress to mitosis in a brief post-mitotic period. However, the advancement of mitosis shows that the levels of mitotic cyclin and other mitotic activators are sufficient for mitosis midway through interphase. Thus, these factors do not normally limit final entry into mitosis during the blastoderm cycles, consistent with previous analysis suggesting that cyclin accumulation is not the direct timer of mitotic entry ([@bib22]; [@bib23]). Importantly, the data suggest that DNA replication produces a negative signal that defines interphase length and directs its normal extension during the blastoderm divisions.

Geminin injection promotes premature chromatin condensation and mitosis with unreplicated chromatids
----------------------------------------------------------------------------------------------------

Embryos coexpressing Cid-GFP and Histone-RFP were injected with Geminin to examine whether deletion of S phase affected chromatin dynamics. In the affected interphase, nuclei decondensed normally after telophase, but less than 3.5 min into interphase chromatin began to recondense ([Fig. 2 B](#fig2){ref-type="fig"} and [Video 4](http://www.jcb.org/cgi/content/full/jcb.200906191/DC1)). Within 1--2 min the chromatin was a compact mass in the center of the nucleus. Shortly thereafter, nuclear envelope breakdown and initial chromatid movements occurred. The early compaction contrasts to wild-type embryos, wherein chromatin begins to condense 8 min into cycle 12 or 13.5 min into cycle 13, just before mitotic entry ([Fig. 2 A](#fig2){ref-type="fig"}, [Video 3](http://www.jcb.org/cgi/content/full/jcb.200906191/DC1), and unpublished data). Hence, deleting S phase in the early mitotic cycles promotes premature DNA condensation and advances mitotic entry.

![**Geminin injection promotes premature chromatin condensation and mitosis with unreplicated chromatids.** Frames showing nuclei from embryos expressing Histone-RFP and Cid-GFP in the cycle after injection with control buffer (A) or Geminin (B). In the Geminin-injected embryo, chromatin begins to condense ∼3 min into interphase, kinetochores are unpaired in mitosis, and chromosomes fail to congress to the metaphase plate. Time is presented as min:sec. (C) Higher magnification view of Cid-GFP during mitosis in control and Geminin injections. Bifurcated arrows in the control nucleus point to paired kinetochores at metaphase. Single arrows in Geminin injection highlight unpaired kinetochores.](JCB_200906191_RGB_Fig2){#fig2}

Control metaphases exhibit eight stably aligned binemic chromosomes whose paired centromeres are detected as two dots of Cid-GFP ([Fig. 2](#fig2){ref-type="fig"} and Video 3). In contrast, after S phase deletion, mitotic chromosomes appeared uninemic, oscillated unstably, and possessed a single Cid-GFP dot ([Fig. 2](#fig2){ref-type="fig"} and Video 4). Thus, in a cycle after Geminin injection, nuclei enter mitosis with single sister chromatids and fail to bi-orient. Real-time imaging of other mitotic proteins, GFP-Polo and Aurora B-GFP, supports the conclusion that S phase deletion advances mitosis with uninemic chromosomes ([Fig. S2](http://www.jcb.org/cgi/content/full/jcb.200906191/DC1) and [Videos 5](http://www.jcb.org/cgi/content/full/jcb.200906191/DC1) and [6](http://www.jcb.org/cgi/content/full/jcb.200906191/DC1)).

Despite the lack of metaphase alignment, nuclei of Geminin-injected embryos exited mitosis after a brief mitotic delay. The total length of mitosis was nearly doubled in cycle 13 ([Fig. 1 D](#fig1){ref-type="fig"}), as chromosomes oscillated for ∼8 min before anaphase onset ([Fig. 2 B](#fig2){ref-type="fig"} and Video 4). We conclude that unreplicated chromosomes delay mitotic progression.

S phase deletion does not advance mitosis in *grp* mutant embryos
-----------------------------------------------------------------

It has been argued that the exponential increase in DNA titrates replication components and slows S phase, which, via checkpoint activation, delays mitosis to create the gradual lengthening of blastoderm cycles ([@bib34]; [@bib4]). If the activity of a checkpoint gene, such as *grp,* relies on DNA replication, the deletion of S phase by Geminin injection should prevent its activation. In this case, a *grp* mutation will have no additional phenotype in a cycle lacking S phase. Furthermore, if all of the effects of DNA replication on mitosis are mediated by *grp*, the mitotic phenotype of *grp* and deletion of S phase ought to be the same. To probe this we compared *grp* mutant embryos to those in which S phase was deleted.

Histone-GFP--expressing embryos, which were wild type, mutant in *grp*, or injected with Geminin, were filmed at high resolution. In contrast to the very early condensation of chromatin after S phase deletion, chromatin in *grp* mutant embryos remain dispersed until the close of interphase ([Fig. 3 A](#fig3){ref-type="fig"}). Furthermore, Geminin injection into *grp* mutant embryos results in chromatin condensation behavior indistinguishable from Geminin injection into wild-type embryos. Thus, DNA replication promotes chromatin dispersal, and dispersal does not require checkpoint function. In cycle 14, the dispersed interphase appearance of chromatin is not dependent on S phase (see below and [Fig. 4](#fig4){ref-type="fig"}), suggesting a change in the dependence on S phase for chromatin dispersal.

![**Direct cell cycle comparison between embryos injected with Geminin and *grp* mutant embryos.** (A) Either wild-type or *grp* mutant embryos expressing Histone-GFP were injected with control buffer or Geminin. Time is presented in min:sec. (B) Quantification of interphase chromatin dynamics and mitotic duration from embryos in A. Nuclear envelope formation (NEF) to the beginning of chromatin condensation was measured and the time from chromatin condensation to the onset of mitosis was measured (onset of mitosis was defined by disappearance of the Histone-GFP halo around the chromatin and the first chromatid movements). Average cell cycle times are shown for wild-type (*n* = 8 embryos), *grp* (*n* = 18 embryos), Geminin injected (*n* = 10 embryos), and Geminin injected into *grp* (*n* = 11 embryos). Error bars represent SD.](JCB_200906191_GS_Fig3){#fig3}

Despite differences in chromatin condensation, Geminin-injected embryos and *grp* mutant embryos exhibited similar mitotic entry times ([Fig. 3 B](#fig3){ref-type="fig"}). Furthermore, *grp* mutants injected with Geminin exhibited similar interphase duration as wild-type embryos injected with Geminin ([Fig. 3](#fig3){ref-type="fig"}). This result suggests that Grapes has no activity after Geminin injection, and that the shortening of interphase in the cycle after Geminin injection might be attributable to the absence of the checkpoint pathway when S phase is deleted. These findings support the previous inference that S phase delays entry into mitosis until its completion by activating Grapes-dependent checkpoint function.

Although Geminin injection into *grp* mutants barely altered interphase length, it still prolonged mitosis, presumably because it induced spindle checkpoint function in response to uninemic chromatids. However, the mitotic delay caused by Geminin injection into *grp* embryos was almost twice that caused by Geminin injection into wild-type embryos ([Fig. 3 B](#fig3){ref-type="fig"}). Perhaps the additional mitotic extension in *grp* mutants reflects a role of Grapes in mitosis or the spindle checkpoint ([@bib39]).

DNA replication at the MBT is required for prompt termination of the syncytial divisions
----------------------------------------------------------------------------------------

The switch from maternal to zygotic control at the MBT is accompanied by changes in cell cycle regulation ([@bib26]). The literature has emphasized that a G2 phase is added to the cell cycle, and that zygotic transcription times subsequent mitoses. However, the first MBT change in the cell cycle is prolongation of S phase. We directly tested whether this S phase has a role in the MBT.

Geminin was injected into embryos expressing Histone-GFP during cycle 13 ([Fig. 4 A](#fig4){ref-type="fig"}). After progressing normally through mitosis 13, nuclei at the injected pole synchronously entered mitosis ∼16.5 min after the onset of cycle 14 ([Fig. 4, A and C](#fig4){ref-type="fig"}; and [Video 7](http://www.jcb.org/cgi/content/full/jcb.200906191/DC1)), whereas mitosis 14 normally occurs in a spatial program beginning 70 min after mitosis 13. These data indicate that S phase 14 is required to terminate the syncytial mitotic cycles.

![**Geminin injection induces an extra syncytial division, but does not affect interphase length after the MBT.** (A) Histone-GFP--expressing embryos were injected at one pole (left) during cycle 13 with Geminin. Note that nuclei synchronously and prematurely enter mitosis 14 in the injected region. (B) Histone-GFP--expressing embryos were injected with Geminin during interphase 14 before cellularization. Bifurcated arrows highlight normal anaphases during mitosis 14 and arrows show unreplicated chromosomes in mitosis 15 that fail to reach the metaphase plate. (C) Quantification of interphase and mitotic duration from embryos as in A and B. Average interphase and mitotic times are shown for cycle 14 (*n* = 13 embryos) and cycle 15 in domain 5 (*n* = 33 embryos). Error bars represent SD.](JCB_200906191_GS_Fig4){#fig4}

To assess the influence of S phase 14 deletion on MBT events, we monitored cellularization. Geminin was injected during cycle 13 into embryos expressing Histone-RFP and Sqh-GFP. Only one extra synchronous division was observed, and this was followed by cellularization, only slightly delayed compared with the uninjected end of the embryo ([Video 8](http://www.jcb.org/cgi/content/full/jcb.200906191/DC1)). Surprisingly, a subsequent division exhibited a normal mitosis 14 domain pattern (unpublished data). Apparently, S phase 14 forestalls mitosis, but other MBT events, which introduce zygotic programming of gastrulation and the cell cycle, continue in its absence ([@bib5]).

S phase is not required for the zygotic programming of a post-MBT mitosis
-------------------------------------------------------------------------

Geminin injection in cycle 14 had no effect until the next cycle, when cells entered a normally patterned mitosis 15 with unreplicated chromatids ([Fig. 4, B and C](#fig4){ref-type="fig"}; [Fig. S3](http://www.jcb.org/cgi/content/full/jcb.200906191/DC1) and [Video 9](http://www.jcb.org/cgi/content/full/jcb.200906191/DC1)). To probe for subtle timing defects, we tracked individual cells during cycle 15. The fifth group of cells to initiate mitosis 14, domain 5, does so relatively synchronously ([@bib12]), but the program is more complex at entry into mitosis 15 (Fig. S3 and [Video 10](http://www.jcb.org/cgi/content/full/jcb.200906191/DC1)). Cells proximal to the cephalic furrow divide earliest at ∼60.5 min after mitosis 14. Geminin-injected embryos showed a slight advancement of mitosis in these cells to 52.75 min. Notably, deletion of S phase 15 did not normalize interphase duration in domain 5, as cells anterior to the first-dividing cells still showed a later mitosis (Fig. S3 and Video 9). Thus, deletion of S phase may have slightly shortened cycle 15, but it did not override inputs that spatially pattern mitosis.

Other observations also support an interpretation that zygotic programming of post-MBT mitoses is independent of S phase. First, although deletion of S phase 14 caused rapid entry into an extra mitosis, this was followed by MBT events and a mitosis that closely followed the normal temporal program of mitosis 14. Second, previous analyses of *dup* mutant embryos, which lack S phase 16, show a normally patterned mitosis 16 ([@bib14]). Post-MBT divisions are normally promoted by Cdc25^string^ expression ([@bib7]), which is guided by the patterning regulators ([@bib10]). This zygotic programming of divisions appears relatively resistant to S phase deletion.

As in the earlier cycles, deletion of S phase resulted in a prolonged mitosis; however, the duration of the prolonged mitoses increased from ∼8.3 min in mitosis 14 to ∼20.5 min in mitosis 15. We do not know the basis of this difference; however, the mitotic delay in both cycles depended on the spindle checkpoint protein Mad2 ([Fig. 5](#fig5){ref-type="fig"}), as has similarly been observed in *dup* mutants in cycle 16 ([@bib14]).

![**The mitotic delay in response to unreplicated sister chromatids is dependent on the spindle checkpoint.** Embryos that were wild type or *mad2* mutant and expressing Histone-GFP were injected with Geminin protein. Mitotic duration was recorded during cycle 14 and cycle 15 in which mitoses occurred with unreplicated sister chromatids. Mitosis 15 duration was measured in multiple mitotic domains and identical results were found. Average mitotic duration is shown for cycle 14 (*n* = 6 embryos) and cycle 15 (*n* = 12 embryos). Error bars represent SD.](JCB_200906191_GS_Fig5){#fig5}

S phase as a mitotic timer
--------------------------

We developed a means to examine the contribution of a normal S phase in timing mitotic entry during early *Drosophila* embryogenesis. Previous work suggests that an S phase checkpoint is activated during a normal S phase ([@bib15]), and that S phase extension is key to the gradual prolongation of the maternally driven blastoderm cycles ([@bib13]; [@bib34], [@bib35]); however, before the results shown here, the role of an undisturbed S phase in timing mitotic entry had not previously been demonstrated. Our results show that a normal S phase is an important timer of interphase length during the syncytial blastoderm cycles.

The role of S phase as a mitotic timer during the maternal divisions does not persist in the zygotically controlled divisions after the MBT. We suggest that this change reflects complete transition to a different mitotic timer. Before the MBT, Cdc25 and other mitotic activators are abundant throughout the cell cycle, there is no evident gap between S phase and mitosis, and nuclei rely on S phase to forestall mitotic entry. After the MBT, many mitotic activators are degraded upon mitotic exit, and restoration of one of these, Cdc25^string^, requires new zygotic transcription ([@bib21]; [@bib7]). Mitosis awaits Cdc25^string^ expression, which usually occurs after completion of S phase, thus introducing a G2 and absolving DNA replication of responsibility for timing mitosis. Notably, this proposal offers an explanation for why the checkpoint genes, which couple mitosis to the completion of S phase, are essential during the early embryonic divisions but subsequently dispensable.

How then does S phase contribute during the beginning of cycle 14 at the MBT? The prolongation of interphase is an important part of the MBT, allowing cellularization and providing enough time for complete transcription of genes with long transcription units ([@bib33]; [@bib12]). The prolongation of interphase and production of G2 phase requires down-regulation of mitotic activators, particularly the activating phosphatases encoded by *string* and *twine*. For example, the inhibitors of String action, Tribbles and Früshstart, which promote Cdc25^string^ destruction and inhibit cyclin:Cdk1, respectively, are transcribed during the long S phase of cycle 14 ([@bib16]; [@bib32]). Although it has been attractive to view the MBT as a sharp switch from maternal to zygotic control, we suggest that the retooling of cell cycle regulation requires considerable time within interphase 14 and that the prolonged S phase 14 enforces Cdk1 inactivation while MBT transition events progress.

Materials and methods
=====================

Fly stocks
----------

*Drosophila melanogaster* strains were grown on standard cornmeal-yeast medium. Flies expressing Histone H2AvD-GFP, GFP-Polo (Fly Trap \#CC01326), Sqh-GFP, Cid-GFP, or Histone H2AvD-RFP were used for live-embryo analysis ([@bib3]; [@bib30]; [@bib2]; [@bib31]). For checkpoint deficient experiments, the following stocks were generated: *w*; *grp^06034^*; *H2AvD-GFP* and *w*; *H2AvD-GFP/Cyo; mad2^p^* ([@bib1]).

The PCNA ORF was amplified using primers 5′-CACCATGTTCGAGGCACGCCTGGGT-3′ and 5′-TGTCTCGTTGTCCTCGATCTTG-3′ and cloned into the gateway system pENTR-D-TOPO vector (Invitrogen) according to the manufacturer\'s instructions. The resulting clone was used to recombine the PCNA ORF into pPVW (UASp promoter with N-terminal venus fusion from the *Drosophila* Gateway collection; T. Murphy Laboratory, Carnegie Institute of Washington, Baltimore, MD). P{UASp-YFP-PCNA} lines were obtained by standard germ-line transformation (BestGene, Inc.). Resulting lines were crossed to Da-Gal4 flies (Daughterless promoter) for YFP-PCNA expression.

Similarly, P{UASp-Aurora B-GFP} lines were constructed. The Aurora B ORF was amplified using primers 5′-CACCATGACGCTTTCCCGCGCGAAG-3′ and 5′-ATTTCTGGCCGTGTTCTCC-3′ and ultimately recombined into pPWG (UASp promoter with C-terminal GFP fusion). Resulting lines were crossed to Tub-Gal4 flies ([@bib20]) for Aurora B-GFP expression.

Embryo manipulation
-------------------

*Drosophila* embryos were collected on agar plates containing grape juice, aged for the appropriate developmental time, dechorionated for 2 min in 50% bleach, and then extensively washed in water. For injections, embryos were aligned on agar plates and transferred to coverslips. Embryos were desiccated for ∼8--10 min and then overlaid with Halocarbon oil (Sigma-Aldrich). Alexa 546--conjugated dUTP (Invitrogen) was injected at a needle concentration of 100 µM.

Geminin protein purification
----------------------------

The *Drosophila* Geminin ORF was amplified using primers 5′-AAACATATGTCTTCGAGCGCTGCCAGG-3′ and 5′-AAACTCGAGCTAGGCGTTGACCTTGTCCTC-3′ and cloned into Pet28a as an NdeI--Xho fragment. 6XHis-Geminin was expressed in BL-21 DE3 pLysS bacteria (Agilent Technologies) and purified on nickel agarose beads according to the manufacturer\'s instructions (QIAGEN). Geminin protein was dialyzed into 40 mM Hepes, pH 7.4, and 150 mM KCl and concentrated to ∼20 mg/ml before injection.

Image acquisition and processing
--------------------------------

Embryos were imaged on an inverted microscope (DM 1RB; Leica) equipped with a spinning-disk confocal unit (CSU10; Yokagowa), 100x Plan Fluotar 1.3 NA and 40x Plan Fluotar 0.7 NA objectives (Lecia), a camera (Orca AG; Hamamatsu Photonics), and Volocity 4 acquisition software (PerkinElmer). Image stacks were collected using 1.5-µm steps over an 8--12-µm range using a controlled stage (MS-2000; Applied Scientific Instrumentation). All images and videos were processed in Volocity 4 software and presented as extended focused images. Image capture rates are indicated per video. Time is displayed in hours:minutes:seconds.

At least three independent experiments were performed for each experiment shown. In each experiment an X-Y stage facilitated the filming of multiple embryos (usually greater than five embryos).

Fixed analysis and immunofluorescence
-------------------------------------

Embryos injected with Geminin were incubated for the appropriate time, fixed in a mixture of 37% formaldehyde and heptane for 10 min, and immediately hand devitellinized. Embryos were washed into phosphate-buffered saline containing 2 µg/ml Hoescht 33258 (Invitrogen) and 2 µg/ml Oregon green--conjugated wheat germ agglutinin (Invitrogen).

Online supplemental material
----------------------------

Fig. S1 illustrates the absence of DNA replication after Geminin injection. Fig. S2 highlights the dynamics of mitotic proteins during the blastoderm division after the deletion of S phase. Fig. S3 provides a wide-field perspective of the post-MBT divisions after deletion of S phase 15. Videos 1--6 show real-time videos of blastoderm embryos progressing through interphase and mitosis after deletion of S phase. Videos 7--8 highlight the effects of S phase deletion on MBT events. Videos 9--10 highlight developmental and cell cycle behavior upon deletion of S phase 15. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200906191/DC1>.
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